Proteomic analysis to identify markers for response to treatment in esophageal cancer.

被引：0
|
作者：
Zlotnik, Oran
Goshen-Lago, Tal
Brenner, Baruch
Kundel, Yulia
Menasherov, Nikolai
Kashtan, Hanoch
Ben-Aharon, Irit
机构：
[1] Rabin Med Ctr, Petah Tiqwa, Israel
[2] Davidoff Ctr Rabin Med Ctr, Petah Tiqwa, Israel
[3] Rabin Med Ctr Oncol, Davidoff Ctr, Hod Hasharon, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.61
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
61
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A National Cancer Database analysis of treatment utilization and associated outcomes in elderly patients with locally advanced esophageal cancer.
    Vlacich, Gregory Riccardo
    Samson, Pamela Parker
    Perkins, Stephanie Mabry
    Roach, Michael Charles
    Parikh, Parag J.
    Bradley, Jeffrey D.
    Lockhart, Albert C.
    Puri, Varun
    Meyers, Bryan F.
    Kozower, Benjamin D.
    Robinson, Cliff Grant
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [32] A validated miRNA expression profile for response to neoadjuvant therapy in esophageal cancer.
    Skinner, Heath D.
    Xu, Enping
    Lee, Jeffrey H.
    Bhutani, Manoop S.
    Weston, Brian
    Suzuki, Akihiro
    Hofstetter, Wayne Lewis
    Komaki, Ritsuko
    Ajani, Jaffer A.
    Wu, Xifeng
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [33] Neutrophil to lymphocyte ratios and pathologic response to neoadjuvant therapy in esophageal cancer.
    Bronson, Nathan W.
    Luna, Renato
    Bloker, Lisa M.
    Douthit, Miriam A.
    Diggs, Brian S.
    Dolan, James P.
    Hunter, John G.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [34] Locally advanced esophageal cancer.
    Sherman C.A.
    Turrisi A.T.
    Wallace M.B.
    Reed C.E.
    Current Treatment Options in Oncology, 2002, 3 (6) : 475 - 485
  • [35] Perioperative therapy for esophageal cancer.
    Yamasaki M.
    Miyata H.
    Miyazaki Y.
    Takahashi T.
    Kurokawa Y.
    Nakajima K.
    Takiguchi S.
    Mori M.
    Doki Y.
    General Thoracic and Cardiovascular Surgery, 2014, 62 (9) : 531 - 540
  • [36] Metabolomic signature of esophageal cancer.
    Davis, Vanessa Wylie
    Schiller, Dan E.
    Sawyer, Michael B.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [37] A CRISPRi screen to identify combination therapies for improved treatment of ovarian cancer.
    Handly, Erika D.
    Kong, Yi Wen
    Braun, Christian J.
    Patterson, Jesse C.
    Yaffe, Michael B.
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 61 - 61
  • [38] Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and response
    Vinik, Yaron
    Ortega, Francisco Gabriel
    Mills, Gordon B.
    Lu, Yilling
    Jurkowicz, Menucha
    Halperin, Sharon
    Aharoni, Mor
    Gutman, Mordechai
    Lev, Sima
    SCIENCE ADVANCES, 2020, 6 (40)
  • [39] Next-generation sequencing to identify predictors of survival after trimodality therapy for esophageal cancer.
    Oh, Patrick
    Zhang, Minsi
    Brady, Paul
    Sihag, Smita
    Molena, Daniela
    Ilson, David H.
    Janjigian, Yelena Yuriy
    Ku, Geoffrey Yuyat
    Wu, Abraham Jing-Ching
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [40] A Meta-Analysis of Proteomic Blood Markers of Colorectal Cancer
    Chen, Xiang
    Sun, Jiayu
    Wang, Xue
    Yuan, Yumeng
    Cai, Leshan
    Xie, Yanxuan
    Fan, Zhiqiang
    Liu, Kaixi
    Jiao, Xiaoyang
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (06) : 1176 - 1196
12345